Screening for Multidrug-resistant (MDR) Gram-negative Organisms and Progression to Bloodstream Infections in Hematopoietic Cell Transplant (HCT) Patients: a Single-center Pilot Study | Zendy

AI Assistant Blog Pricing

Screening for Multidrug-resistant (MDR) Gram-negative Organisms and Progression to Bloodstream Infections in Hematopoietic Cell Transplant (HCT) Patients: a Single-center Pilot Study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.